Welcome to our dedicated page for BRSFD news (Ticker: BRSFD), a resource for investors and traders seeking the latest updates and insights on BRSFD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BRSFD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BRSFD's position in the market.
Brain Scientific has announced a significant distribution agreement with Hansraj Nayyar Medical – India Pvt. Ltd., expanding its market presence in India. This partnership aims to unlock the Indian medical device market, known for its extensive hospital network. The collaboration is expected to enhance Brain Scientific's distribution capabilities and sales of its neurology devices, particularly the NeuroCap™ and NeuroEEG™. CEO Hassan Kotob emphasized the growing demand for their innovative neurological testing solutions. The partnership aligns with the company's strategy to lead in the medical wearables sector.
Piezo Motion, a subsidiary of Brain Scientific (OTCQB:BRSFD), reports a surge in demand for its innovative RAS Series piezomotors, notably from a leading photonics company, marking its largest order to date. Additionally, the company secured orders for its non-magnetic high-torque motor from the University of Hawaii and a U.S. medical robotics designer, emphasizing its application in medical MRI robotics. CEO Hassan Kotob highlighted the motors’ affordability and efficiency, positioning them for widespread industrial use. Piezo Motion holds 27 patents, serving diverse markets like life science, aerospace, and automotive systems.
Brain Scientific (OTCQB:BRSFD) is collaborating with Life After PTSD to integrate its NeuroCapTM and NeuroEEGTM system into a PTSD treatment protocol. This partnership aims to enhance the Managing Emotional States Effectively© (MESE) protocol, currently utilized by 80 practitioners on over 1,500 patients. The MESE protocol is designed to help patients address traumatic memories safely, guided by trained professionals. CEO Hassan Kotob emphasized the importance of their integrated EEG solution in advancing PTSD treatment. The collaboration seeks to expand mental health support across the United States.
Brain Scientific has announced a significant order for its NeuroCap from MVAP Medical Supplies. This partnership aims to expand sales and distribution in key markets, particularly for pediatric neurodiagnostic applications. Eric Jensen, CEO of MVAP, praised the NeuroCap for its ease of use and performance, highlighting its potential in enhancing patient care. Brain Scientific’s commitment to innovation is evident in its dual product lines, which include FDA-cleared devices like the NeuroCap™ and advanced piezo motors. This collaboration is expected to strengthen Brain Scientific's position in the growing medical wearables sector.
FAQ
What is the market cap of BRSFD (BRSFD)?
